CCOc1ccc(-c2nc(Cn3ccn4nc(-c5ccc(OCC)c(Cl)c5)cc4c3=O)c(C)o2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?